FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The authors note that the incidence of port-site metastases associated with robotic radical cystectomy for bladder cancer was slightly higher than the reported incidence associated with laparoscopic surgery for combined genitourinary cancers (0.09%), prostate cancer (0.1%), and kidney cancers (0.1%). In contrast, this rate was lower when compared to robotic surgeries for gynecologic cancers (1.1% to 1.9%.).
The investigators also point out that the incidence of incision-site metastases with open cystectomy is also not well described. Systematic reporting of port-site metastases is critical to define the optimal strategies for prevention and treatment of this dreaded complication
Read the Abstract
Author: Bishoy M. Faltas MD
Khetrapal P, Shen Tan W, Lamb B, Nathan S, Briggs T, Shankar A, Ramachandran N, Freeman A, Mitra A, Kelly JD. Port-Site Metastases After Robotic Radical Cystectomy: A Systematic Review and Management Options. Clin Genitourin Cancer. 2016 Jun 29. pii: S1558-7673(16)30163-X. doi: 10.1016/j.clgc.2016.06.012. [Epub ahead of print]